Literature DB >> 12613582

Involvement of cytokines in the pathogenesis of systemic lupus erythematosus.

B R Lauwerys1, F A Houssiau.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12613582     DOI: 10.1007/978-1-4615-0171-8_14

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  5 in total

1.  The analysis of CIS, SOCS1, SOSC2 and SOCS3 transcript levels in peripheral blood mononuclear cells of systemic lupus erythematosus and rheumatoid arthritis patients.

Authors:  Jeng-Ting Tsao; Chia-Chen Kuo; Shih-Chang Lin
Journal:  Clin Exp Med       Date:  2008-09-27       Impact factor: 3.984

Review 2.  Accelerated atherosclerosis in systemic lupus erythematosus: role of proinflammatory cytokines and therapeutic approaches.

Authors:  Chary López-Pedrera; Maria Ángeles Aguirre; Nuria Barbarroja; Maria José Cuadrado
Journal:  J Biomed Biotechnol       Date:  2010-09-26

3.  Effect of proinflammatory cytokines (IL-6, TNF-α, and IL-1β) on clinical manifestations in Indian SLE patients.

Authors:  Vinod Umare; Vandana Pradhan; Milind Nadkar; Anjali Rajadhyaksha; Manisha Patwardhan; Kanjaksha K Ghosh; Anita H Nadkarni
Journal:  Mediators Inflamm       Date:  2014-12-07       Impact factor: 4.711

4.  Anti-Inflammatory Effects of Four Psilocybin-Containing Magic Mushroom Water Extracts in vitro on 15-Lipoxygenase Activity and on Lipopolysaccharide-Induced Cyclooxygenase-2 and Inflammatory Cytokines in Human U937 Macrophage Cells.

Authors:  Sanah Malomile Nkadimeng; Christiaan M L Steinmann; Jacobus N Eloff
Journal:  J Inflamm Res       Date:  2021-08-05

5.  Xiao Qing Long Tang essential oil exhibits inhibitory effects on the release of pro-inflammatory mediators by suppressing NF-κB, AP-1, and IRF3 signalling in the lipopolysaccharide-stimulated RAW264.7 cells.

Authors:  Gan Luo; Jing Kong; Brian Chi-Yan Cheng; Hui Zhao; Xiu-Qiong Fu; Li-Shan Yan; Yu Ding; Yan-Ling Liu; Si-Yuan Pan; Shuo-Feng Zhang; Yi Zhang
Journal:  RSC Adv       Date:  2019-04-26       Impact factor: 4.036

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.